OECD Green Talks LIVE - Evaluating the economic benefits of environmental policies that save lives.pdf

OECD_ENV 1 views 17 slides Oct 02, 2025
Slide 1
Slide 1 of 17
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17

About This Presentation

Every potential policy measure affecting human health – from seat belt laws to chemicals regulations – involves both economic costs and benefits. Stricter vehicle fuel efficiency standards may lead to higher costs for consumers and businesses, but they also save lives through improved air qualit...


Slide Content

Evaluating the economic
benefits of environmental
policies that save lives
Olof Byström
OECD Environment Directorate
Join the conversation:
#GreenTalks
OECD Environment on LinkedIn
@OECD_ENV on X 1 October 2025
Launch of the OECD report Mortality Risk
Valuation in Policy Assessment
Henrik Lindhjem
Menon Economics
Ståle Navrud
Norwegian University of Life Sciences

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
2How to place a value on mortalityrisk
Surveys
(Stated preference)
What if?
Observed behaviour
(Revealed preference)
Small payment for small change in mortality risk, aggregated to a probability of 1
Value of Statistical Life (VSL) or Value of a Prevented Fatality
Related concepts:
VSLY, QALY, DALY

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
3OECD’s work previous on the VSL
›Published in 2012
›Stated preference studies only
›1970 – 2008 time frame
›405 VSL estimates

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
4
Nearly all academic and grey
literature in English between
1970 to 2023
4 000 estimates from 49
countries

Updating the OECD’s valuations of mortality risk
EXPANDED LITERATURE GREATER POOL
OF STUDIES
IMPROVED
METHODOLOGY
Both stated preference and
revealed preference
approaches
Replicable systematic meta
data collection and improved
meta-analysis techniques
VSL by country groups and updated guidance on benefit transfer
Supported by advisory group
of leading academic experts

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
5Geographical distribution of studies (1970 – 2023)
Stated preference studies Revealed preference studies

METHODOLOGY

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
7Three steps of the study
VSL database with
information coded
as variables
Recommended VSL
estimates for policy
VSL estimates from primary
studies
Base estimates and ranges
for country groups
Factors considered:
•Methods used
•Risk characteristics
•Other (e.g. Country, year)
Adjustment factor for
specific uses:
•Income differences
across countries and over
time
Meta-analysis
&
regressions
Value
transfer
principles
&
methods
Meta-data Analysis Recommendations

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
8The study used meta-data on VSL from 2009-2023
Stated preference estimates Revealed preference estimates
›The most important health
endpoints for the VSL
estimates are:
•Cancer
•Respiratory diseases
•Cardiovascular diseases

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
9Data conversion, coding and screening
Variables extracted and coded into meta-database from primary studies
Extreme outliers excluded (aka “far-outs”)
No adjustment for income growth
Estimates adjusted to 2022 local currency values and converted to USD

KEY FINDINGS

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
11
Mean preliminary unweighted VSL estimates* by country group
* Estimated means based on analysis of meta-data for the 2009-2023 period by country group using a 4-level random-effects model
All countries (N=156)
OECD (N=108)
High-incomecountries (N=113)
United States (N=38)
EuropeanUnion (N=37)
Low-and middle-income
countries (N=43)
PUVSL (2022 USD million)
0 1 2 3 4 5 6 7 8 9 10
5.5
7.1
7.6
7.2
7.1
0.9

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
12Meta-regression results and sensitivity
›Mean VSL is not very sensitive to the estimation approach (Revealed vs Stated preferences) and
is instead more impacted by elicitation method within each approach:
•Consumer market studies give lower estimates, hedonic wage studies are higher, and stated preference
methodologies (CV and CE) are in the middle
›Income elasticity of VSL is robust and most estimates suggest a number around 1
(between 0.5 and 1.5)

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
13Summary of evidence on adjustment factors
CHILDREN AGE
CANCER
PANDEMICS/
OTHER CAUSES
Uncertain/ limited evidence of
higher VSL
Mostly inverted U-shape, but
hard to operationalise
Regression results suggest a 2X factor for
VSL based on cancer risk
However, cancers are very heterogenous
and hard to generalise
Limited evidence for any
deviations from base
Except for GDP per capita, no other factors are suggested for adjusting base VSL

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
14
Base VSL values and range
(based on population-weighted GDP per capita)
0
2
4
6
8
10
12
Global OECD EU United States High-income
countries
Low-middle
income countries
8.4 8.5
7.9
1.1
2.7
7.1
Calculated Median VSL
95% Confidence Band
Base VSL (Mean)
USD 2022 Million

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
15Using the numbers in practice
›Very heterogenous data and contexts for use of VSL estimates
→Advantages of adopting simple, general guidelines that are widely applicable
›Many countries do not have VSL guidance and could use the following formula to derive national VSL
estimate :
•??????????????????????????????????????????
�=??????????????????????????????????????????
�∗
??????????????????????????????????????????????????????�????????????
�
??????????????????????????????????????????????????????�????????????
�
•Use base VSL estimates from the smallest group to which the country belongs
•Assume income elasticity of VSL of 1
›Adjust over time with real income growth and appropriate discount rate
›Adjusting base VSL with age, risk types/ causes or other factors is not recommended
› Different VSLs across countries? Generally yes
Country j in country group i

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
16Summary
›Most comprehensive review and meta-analysis of the global VSL literature to date
›Robust «base» VSL estimates derived for use in policy assessment internationally and for
individual countries
›Data allows for testing alternative assumptions such as type of valuation method and income
elasticity
›Benefit Transfer to non-surveyed country using GDP per capita and income elasticity of 1

Restricted Use - À usage restreintRestricted Use - À usage restreint ENV Directorate
17
Scan the QR code to
download the full report
Visit: oe.cd/VSL